Suppr超能文献

脂肪细胞在乳腺癌微环境和宏环境中的促肿瘤作用。

The Tumor Promotional Role of Adipocytes in the Breast Cancer Microenvironment and Macroenvironment.

机构信息

Department of Pharmacology and Toxicology and Nicolas V. Perricone Division of Dermatology, Department of Medicine, Michigan State University, East Lansing, Michigan.

Department of Pathology, Stephenson Cancer Center, and Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.

出版信息

Am J Pathol. 2021 Aug;191(8):1342-1352. doi: 10.1016/j.ajpath.2021.02.006. Epub 2021 Feb 24.

Abstract

The role of the adipocyte in the tumor microenvironment has received significant attention as a critical mediator of the obesity-cancer relationship. Current estimates indicate that 650 million adults have obesity, and thirteen cancers, including breast cancer, are estimated to be associated with obesity. Even in people with a normal body mass index, adipocytes are key players in breast cancer progression because of the proximity of tumors to mammary adipose tissue. Outside the breast microenvironment, adipocytes influence metabolic and immune function and produce numerous signaling molecules, all of which affect breast cancer development and progression. The current epidemiologic data linking obesity, and importantly adipose tissue, to breast cancer risk and prognosis, focusing on metabolic health, weight gain, and adipose distribution as underlying drivers of obesity-associated breast cancer is presented here. Bioactive factors produced by adipocytes, both normal and cancer associated, such as cytokines, growth factors, and metabolites, and the potential mechanisms through which adipocytes influence different breast cancer subtypes are highlighted.

摘要

脂肪细胞在肿瘤微环境中的作用作为肥胖与癌症关系的关键介质受到了极大关注。目前估计有 6.5 亿成年人肥胖,有 13 种癌症,包括乳腺癌,被认为与肥胖有关。即使在体重指数正常的人群中,由于肿瘤靠近乳腺脂肪组织,脂肪细胞也是乳腺癌进展的关键参与者。在乳腺微环境之外,脂肪细胞影响代谢和免疫功能,并产生许多信号分子,所有这些都影响乳腺癌的发生和发展。这里介绍了目前将肥胖,尤其是脂肪组织与乳腺癌风险和预后联系起来的流行病学数据,重点关注代谢健康、体重增加和脂肪分布作为肥胖相关乳腺癌的潜在驱动因素。强调了脂肪细胞产生的生物活性因子,包括正常和与癌症相关的细胞因子、生长因子和代谢物,以及脂肪细胞影响不同乳腺癌亚型的潜在机制。

相似文献

1
The Tumor Promotional Role of Adipocytes in the Breast Cancer Microenvironment and Macroenvironment.
Am J Pathol. 2021 Aug;191(8):1342-1352. doi: 10.1016/j.ajpath.2021.02.006. Epub 2021 Feb 24.
2
The obese inflammatory microenvironment may promote breast DCIS progression.
Front Immunol. 2024 Jul 12;15:1384354. doi: 10.3389/fimmu.2024.1384354. eCollection 2024.
5
Tumour-surrounding adipocytes are active players in breast cancer progression.
Ann Endocrinol (Paris). 2013 May;74(2):108-10. doi: 10.1016/j.ando.2013.02.007. Epub 2013 Apr 6.
6
Cancer-associated adipocytes: key players in breast cancer progression.
J Hematol Oncol. 2019 Sep 10;12(1):95. doi: 10.1186/s13045-019-0778-6.
8
The obese adipose tissue microenvironment in cancer development and progression.
Nat Rev Endocrinol. 2019 Mar;15(3):139-154. doi: 10.1038/s41574-018-0126-x.
9
Adipocytes in Breast Cancer, the Thick and the Thin.
Cells. 2020 Feb 27;9(3):560. doi: 10.3390/cells9030560.
10
Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.
Cancer Prev Res (Phila). 2017 Sep;10(9):494-506. doi: 10.1158/1940-6207.CAPR-16-0322.

引用本文的文献

2
Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer.
Cells. 2025 Feb 15;14(4):286. doi: 10.3390/cells14040286.
5
Adipsin-dependent adipocyte maturation induces cancer cell invasion in breast cancer.
Sci Rep. 2024 Aug 9;14(1):18494. doi: 10.1038/s41598-024-69476-3.
6
SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer.
Immunol Res. 2024 Oct;72(5):1030-1050. doi: 10.1007/s12026-024-09505-5. Epub 2024 Jun 18.
8
Breast Cancer Exposomics.
Life (Basel). 2024 Mar 18;14(3):402. doi: 10.3390/life14030402.
9
The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism.
Front Endocrinol (Lausanne). 2023 Sep 20;14:1217875. doi: 10.3389/fendo.2023.1217875. eCollection 2023.
10
Mature white adipocyte plasticity during mammary gland remodelling and cancer.
Cell Insight. 2023 Aug 20;2(5):100123. doi: 10.1016/j.cellin.2023.100123. eCollection 2023 Oct.

本文引用的文献

1
Extracellular Matrix-Bound FGF2 Mediates Estrogen Receptor Signaling and Therapeutic Response in Breast Cancer.
Mol Cancer Res. 2021 Jan;19(1):136-149. doi: 10.1158/1541-7786.MCR-20-0554. Epub 2020 Oct 8.
2
Cancer-associated adipocytes: emerging supporters in breast cancer.
J Exp Clin Cancer Res. 2020 Aug 12;39(1):156. doi: 10.1186/s13046-020-01666-z.
3
Obesogenic Memory Maintains Adipose Tissue Inflammation and Insulin Resistance.
Immunometabolism. 2020;2(3). doi: 10.20900/immunometab20200023. Epub 2020 Jun 15.
4
Association of obesity status and metabolic syndrome with site-specific cancers: a population-based cohort study.
Br J Cancer. 2020 Oct;123(8):1336-1344. doi: 10.1038/s41416-020-1012-6. Epub 2020 Jul 30.
5
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER Metastatic Breast Cancer.
Clin Cancer Res. 2020 Nov 15;26(22):5974-5989. doi: 10.1158/1078-0432.CCR-19-3958. Epub 2020 Jul 28.
7
Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice.
Nat Commun. 2020 May 8;11(1):2303. doi: 10.1038/s41467-020-16026-w.
8
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer.
NPJ Breast Cancer. 2020 Feb 21;6:6. doi: 10.1038/s41523-020-0149-z. eCollection 2020.
9
Cancer statistics, 2020.
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
10
Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin.
Nutrients. 2019 Nov 20;11(12):2839. doi: 10.3390/nu11122839.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验